Progesterone-targeted magnetic resonance imaging probes.

Area of Science:

• Biomedical Imaging
• Molecular Imaging
• Radiochemistry

Background:

• Progesterone receptor (PR) status is vital for hormone-dependent diseases, impacting prognosis and treatment.
• Current methods for assessing PR status often require invasive biopsies.
• Noninvasive monitoring using targeted Magnetic Resonance Imaging (MRI) probes could revolutionize disease management.

Purpose of the Study:

• To develop and evaluate novel PR-targeted MR probes for noninvasive assessment of PR status.
• To investigate the impact of chemical modifications on probe delivery, cellular uptake, and targeting efficacy in vivo.
• To determine if intravenous administration of modified steroid-MR probes improves tissue accumulation in PR-rich tissues.

Main Methods:

• Chemical modification of progesterone-gadolinium chelates to enhance water solubility and enable intravenous administration.
• In vitro assessment of probe affinity for PR and cellular toxicity.
• In vivo evaluation of PR-targeted MR probe delivery to PR-rich tissues and tumors.

Main Results:

• Modified MR probes exhibited increased water solubility and reduced cellular toxicity.
• Intravenous administration did not enhance delivery to PR-rich tissues compared to subcutaneous routes.
• Lower PR binding affinity and reduced cell membrane permeability of modified probes limited in vivo targeting efficacy.

Conclusions:

• Optimizing PR-targeted MR probes requires balancing delivery route, receptor binding affinity, and cell permeability.
• Current modifications for intravenous administration compromised probe efficacy for in vivo PR-targeted imaging.
• Further research is needed to refine targeted contrast agents for successful clinical translation in diagnosing and monitoring hormone-dependent diseases.